American Association for Cancer Research (AACR)

Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.

Learn More

Innovators in Discovery

Fellow of the AACR Academy John E. Dick, PhD, earns the 2020 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research.

Learn More

Cancer Types

More than 40,000 people a year in the United States are diagnosed with liver cancer. Learn about this form of cancer including the prevention, screening, and treatment options.

Learn More

Survivor Journeys

Jazz musician and educator Billy Foster continues to work on his music as he battles metastatic kidney cancer.

Read Billy’s Story

AACR Project GENIE

AACR Project GENIE is a publicly accessible international cancer registry of real-world data assembled through data sharing between 19 of the leading cancer centers in the world.

Learn More

Get Involved

Join the AACR Runners for Research and support lifesaving cancer research by participating in race events around the country. You can even participate as a Virtual Runner or create your own event.

Learn More

For Researchers

AACR Annual Meeting

Housing Deadline
March 13, 2020
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research and advocacy, and highlights the work of the best minds in research and medicine from institutions all over the world.

Reserve Now

Videos

Driving Progress Against Cancer

The American Association for Cancer Research (AACR) and our more than 44,000 members worldwide are advancing a scientifically bold agenda against the collection of devastating diseases we call cancer.

Keeping Breast Cancer at Bay with Immunotherapy

Eva was devastated to learn her triple-negative breast cancer had spread to her lungs and sternum, but immunotherapy has allowed her and her husband to enjoy retirement together.

Charles L. Sawyers, MD: Fellow of the AACR Academy

A physician-scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.